Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FA.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ER.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FS.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.54NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
N.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.15 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.348NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.575NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.4 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.442NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.2.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.600NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.12 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.525 (Eta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.7 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.24 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.45 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.70 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.26.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.108 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.32 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.46.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.75.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XMNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.70NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.63NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.8.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EC.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XLNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BD.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.87 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.23.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XNNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.111 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CG.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used